Inflammatory Bowel Disease in the Lens of Sport Medicine

Learning Objectives:

• Distinguish between the signs, symptoms and complications of Ulcerative colitis and Crohn’s Disease
• Accurately assess the severity and disease activity of Ulcerative Colitis (UC) and Crohn’s disease (CD). 
• Justify the use of drug therapies for UC and CD on the basis of risk benefit.
• Develop a monitoring plan to evaluate both the efficacy and the toxicity of drug therapies need in inflammatory Bowel Disease. 

Disclosure: Dr.  has no actual or potential conflict of interest in relation to this program or presentation.

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Illinois Osteopathic Medical Society (IOMS) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.

Grievance Policy: ​Grievances regarding this program or AOA CME credit reporting will be handled on an individual basis. All grievances should be directed in writing to the IOMS Executive Director at ioms@ioms.org or by mail to Illinois Osteopathic Medical Society, 4200 Conestoga Drive, Suite 150, Springfield, IL 62711. Grievances that cannot be resolved by IOMS will then be sent to the AOA Council on CME, 142 East Ontario Street, Chicago, IL 60611.